Details of the Drug Combinations

General Information of This Drug (ID: DM76VHG)

• Drug Name: Regadenoson (DM76VHG)
• Synonyms: Lexiscan (TN)

Indication

Radionuclide imaging; ICD 11: N.A.; Status: Approved [1]

• Drug Type: Small molecular drug

List of Combinatorial Drugs (CBD) Containing This Drug

6 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Gadobenate dimeglumine + Regadenoson	DCTXK15	Gadobenate dimeglumine	Coronary Artery Disease	[2]
Regadenoson + Dobutamine	DCD4AES	Dobutamine	Coronary Artery Disease	[3]
Regadenoson + Adenosine	DCI75AC	Adenosine	Obesity	[4]
Regadenoson + Temozolomide	DCV4ZKH	Temozolomide	Blood Brain Barrier Defect	[5]
Regadenoson + Gadopentetate dimeglumine	DCWOIP6	Gadopentetate dimeglumine	Heart Transplant	[6]
Regadenoson + Adenosine	DCXADT2	Adenosine	Hypertrophic Cardiomyopathy	[7]

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5596).
• [2] ClinicalTrials.gov (NCT03064295) Whole-Heart Myocardial Blood Flow Quantification Using MRI
• [3] ClinicalTrials.gov (NCT00763035) Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)
• [4] ClinicalTrials.gov (NCT00859833) Effects of Body Mass Index on the Hyperemic Response to Regadenoson
• [5] ClinicalTrials.gov (NCT02389738) Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration
• [6] ClinicalTrials.gov (NCT02597543) Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction
• [7] ClinicalTrials.gov (NCT03249272) Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve